---
title: 'clinical efficacy and molecular response correlates of the WEE1 inhibitor adavosertib combined with cisplatin in patients with metastatic triple-negative breast cancer.'
contributors: 'Keenan, T.E., Li, T., Vallius, T., Guerriero, J.L., Tayob, N., Kochupurakkal, B., Davis, J., Pastorello, R., Tahara, R.K., Anderson, L., Conway, J., He, M.X., Shannon, E., Godin, R.E., Sorger, P.K., D'Andrea, A., Overmoyer, B., Winer, E.P., Mittendorf, E.A., Van Allen, E.M., Shapiro, G.I, & Sara M. Tolaney. (2021).'
publication: Clinical Cancer Research, 2(1), 66-82.
publication_link: https://doi.org/10.1158/1078-0432.CCR-20-3089

image: publication/harvard-clinical-efficacy-and-molecular-response-correlates-of-the-WEE1-inhibitor-adavosertib-combined-with-cisplatin-in-patients-with-metastatic-triple-negative-breast-cancer.jpg

group: harvard

date: 2021-01-20

minerva_link:
rxiv_link:
pdf_link:
show_page_link: false
---
